Skip to main content
. 2022 Jun 21;2022(6):CD006404. doi: 10.1002/14651858.CD006404.pub4

1.6. Analysis.

1.6

Comparison 1: Pyronaridine‐artesunate versus artemether‐lumefantrine, Outcome 6: Serious adverse events